HIGHLIGHTS
- who: Lu Guo from the (UNIVERSITY) have published the paper: TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms, in the Journal: (JOURNAL) of 29/09/2021
- what: In this study, TDP43 was identified as an important factor participating in the maintenance of BCSC stemness by increasing CD44v inclusion, especially CD44v8-10. Increasing evidence, including the research , shows that CD44, which is the most common CSC marker, contains various isoforms, and CD44 AS may not be controlled by a single splicing factor or regulatory mode.
- how: Showed that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.